Tags

Type your tag names separated by a space and hit enter

Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design.
J Control Release. 2000 Dec 03; 69(3):455-68.JC

Abstract

The aim of this study was to develop new multi-layer matrix tablets to achieve bimodal drug release profiles (fast release/slow release/fast release). Hydroxypropyl methylcellulose acetate succinate (HPMCAS, type MF) was chosen as a matrix former, because it is water-insoluble at low, and water-soluble at high pH values. Studies focused on the elucidation of the drug release mechanisms from HPMCAS-MF:drug tablets. In 0.1 N HCl the resulting release kinetics can be described using Fick's second law of diffusion, taking into account axial and radial mass transfer in cylindrical geometry. As the diffusion coefficients are found to be constant and the boundary conditions to be stationary, these systems are purely drug diffusion-controlled. In contrast, the dominating mass transport phenomena in phosphate buffer pH 7.4 are more complex. Due to polymer dissolution the resulting matrix structure is time-variant, leading to increasing drug diffusion coefficients and decreasing tablet dimensions, and thus moving boundary conditions. Drug release is affected by water imbibition, drug diffusion and polymer dissolution and is faster compared to 0.1 N HCl. With knowledge of these underlying release mechanisms, multi-layer matrix tablets were developed to achieve bimodal drug release. HPMCAS-MF:drug mixtures were used as tablet cores. As expected, changing the release medium from 0.1 N HCl to phosphate buffer pH 7. 4 after 2 h, lead to a significant increase in drug release. The abruptness of this rate change could be enhanced by adding two drug-free HPMCAS-MF barrier layers (one on each side) to the system. The addition of a fourth, drug-containing and fast disintegrating initial dose layer yielded the desired bimodal drug release patterns. The process and formulation parameters affecting the resulting release rates were investigated using theophylline and acetaminophen as model drugs.

Authors+Show Affiliations

College of Pharmacy, Freie Universität Berlin, Kelchstr. 31, 12169, Berlin, Germany.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11102685

Citation

Streubel, A, et al. "Bimodal Drug Release Achieved With Multi-layer Matrix Tablets: Transport Mechanisms and Device Design." Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 69, no. 3, 2000, pp. 455-68.
Streubel A, Siepmann J, Peppas NA, et al. Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design. J Control Release. 2000;69(3):455-68.
Streubel, A., Siepmann, J., Peppas, N. A., & Bodmeier, R. (2000). Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design. Journal of Controlled Release : Official Journal of the Controlled Release Society, 69(3), 455-68.
Streubel A, et al. Bimodal Drug Release Achieved With Multi-layer Matrix Tablets: Transport Mechanisms and Device Design. J Control Release. 2000 Dec 3;69(3):455-68. PubMed PMID: 11102685.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design. AU - Streubel,A, AU - Siepmann,J, AU - Peppas,N A, AU - Bodmeier,R, PY - 2000/12/5/pubmed PY - 2001/2/28/medline PY - 2000/12/5/entrez SP - 455 EP - 68 JF - Journal of controlled release : official journal of the Controlled Release Society JO - J Control Release VL - 69 IS - 3 N2 - The aim of this study was to develop new multi-layer matrix tablets to achieve bimodal drug release profiles (fast release/slow release/fast release). Hydroxypropyl methylcellulose acetate succinate (HPMCAS, type MF) was chosen as a matrix former, because it is water-insoluble at low, and water-soluble at high pH values. Studies focused on the elucidation of the drug release mechanisms from HPMCAS-MF:drug tablets. In 0.1 N HCl the resulting release kinetics can be described using Fick's second law of diffusion, taking into account axial and radial mass transfer in cylindrical geometry. As the diffusion coefficients are found to be constant and the boundary conditions to be stationary, these systems are purely drug diffusion-controlled. In contrast, the dominating mass transport phenomena in phosphate buffer pH 7.4 are more complex. Due to polymer dissolution the resulting matrix structure is time-variant, leading to increasing drug diffusion coefficients and decreasing tablet dimensions, and thus moving boundary conditions. Drug release is affected by water imbibition, drug diffusion and polymer dissolution and is faster compared to 0.1 N HCl. With knowledge of these underlying release mechanisms, multi-layer matrix tablets were developed to achieve bimodal drug release. HPMCAS-MF:drug mixtures were used as tablet cores. As expected, changing the release medium from 0.1 N HCl to phosphate buffer pH 7. 4 after 2 h, lead to a significant increase in drug release. The abruptness of this rate change could be enhanced by adding two drug-free HPMCAS-MF barrier layers (one on each side) to the system. The addition of a fourth, drug-containing and fast disintegrating initial dose layer yielded the desired bimodal drug release patterns. The process and formulation parameters affecting the resulting release rates were investigated using theophylline and acetaminophen as model drugs. SN - 0168-3659 UR - https://www.unboundmedicine.com/medline/citation/11102685/Bimodal_drug_release_achieved_with_multi_layer_matrix_tablets:_transport_mechanisms_and_device_design_ DB - PRIME DP - Unbound Medicine ER -